Whatever happens to the cardioverted? An audit of the success of direct current cardioversion for atrial fibrillation in a district general hospital over a period of four years

Br J Cardiol 2010;17:86–8 2 Comments
Click any image to enlarge
Authors:

Direct current cardioversion (DCCV) to restore sinus rhythm (SR) in patients with persistent atrial fibrillation (AF) remains a therapeutic option, though recent studies have questioned its need and value in the longer term.

Pay to access this premium content £5

The BJC is introducing a small charge for some of its premium content. On purchase you will receive an email to access the article and have a downloadable PDF to keep. The PDF can be downloaded from a button on the sidebar. Please note the purchase of this article is for your personal use only.
By supporting us in this way, you are helping us to deliver high-quality services to healthcare professionals. We will continue to keep the majority of our content free of charge.


You can access this article without logging in.
But don't miss out on the many Benefits of our Membership. Register Now.
Already a member? Login Now.
2 thoughts on “Whatever happens to the cardioverted? An audit of the success of direct current cardioversion for atrial fibrillation in a district general hospital over a period of four years”